Summary
Serious infection due toBorrelia burgdorferi and the disseminated infection characteristic of the disease possess unique treatment problems. The wide and still increasing incidence of Lyme borreliosis as well as the problems in treatment call for effective prevention strategies by active immunization. Vaccination experiments were done to determine if active immunization of gerbils with recombinant OspA and pC protects against infection with strains ofB. burgdorferi. Gerbils were vaccinated with recombinant OspA and pC (20 kDa protein) and challenged four weeks later with a clone (derived fromB. burgdorferi strain PKo) which expresses an abundant amount of pC but only little OspA. Non-immunized gerbils challenged with the sameB. burgdorferi strain were used as controls. Both groups of immunized gerbils developed antibodies against the recombinant vaccines. The pC vaccinated group was protected against infection, whereas the OspA vaccinated group showed signs of infection. The non-vaccinated group developed generalised infection. These results show that pC should be considered as a further vaccine candidate and probably needs to be combined with OspA for an efficient vaccine againstB. burgdorferi.
Zusammenfassung
Weite Verbreitung und zunehmende Inzidenz der Lyme Borreliose sowie Therapieprobleme bei schweren Erkrankungsformen besonders im Spätstdadium der Infektion sind Gründe für die Entwicklung einer möglichen Alternative zur Antiobitikatherapie wie zum Beispiel Schutzimpfung. Die Schutzwirkung einer aktiven Immunisierung mit rekombinanten OspA und pC gegen die Infektion mitBorrelia burgdorferi wurde bei Gerbils geprüft. Die Tiere wurden mit rekombinanten OspA und pC vomB. burgdorferi-Stamm PKo immunisiert; die Infektion erfolgte vier Wochen nach der Immunisierung mit dem PKo-Stamm (schwache OspA, gute pC Expression). Als Kontrollgruppe dienten infizierte, nicht immunisierte Gerbils. Die immunisierten Tiere bildeten Antikörper gegen rekombinante Vakzine. Die mit pC immunisierten Tiere waren vor der Infektion geschützt, die Kontrollgruppe zeigte eine generalisierte Infektion. Die Immunisierung mit OspA schützte nicht, die Tiere zeigten, wie die Kontrollgruppe Merkmale der Infektion. Die Ergebnisse dieser Studie zeigen, daß pC für eine Immunisierung in Frage kommt. Eine Kombination von OspA und pC scheint für eine effektive Vakzine gegenBorrelia burgdorferi nötig zu sein.
Similar content being viewed by others
References
Burgdorfer, W., Barbour, A. G., Hayes, S. F., Benach, J. L., Grunwald, E., Davis, J. P. Lyme disease — a tick-borne spirochetosis? Science 216 (1982) 1317–1319.
Steere, A. C. Medical progress — Lyme disease. N. Engl. J. Med. 321 (1989) 586–596.
Barbour, A. G., Heiland, R. A., Howe, T. R. Heterogeneity of major proteins in Lyme disease borreliae: a molecular analysis of North American and European isolates. J. Infect. Dis. 152 (1985) 478–484.
Wilske, B., Anderson, J. F., Baranton, G., Barbour, A. G., Hovind-Hougen, K., Johnson, R. C., Preac-Mursic, V. Taxonomy ofBorrelia spp. Scand. J. Infect. Dis. (Suppl. 77) (1991) 108–129.
Jonsson, M., Noppa, L., Barbour, A. G., Bergström, S. Heterogeneity of osp operons of three isolates of different geographic origins. Infect. Immun. 60 (1992) 1845–1853.
Babour, A. G. Antigenic variations of surface proteins ofBorrelia species. Rev. Infect. Dis. 10 (1988) 399–402.
Wilske, B., Preac-Mursic, V., Schierz, G., Kühbeck, R., Barbour, A. G., Kramer, M. Antigenic variability ofBorrelia burgdorferi. Ann. N. Y. Acad. Sci. 539 (1988) 126–143.
Bundoc, V. G., Barbour, A. Clonal polymorphisms of outer membrane protein OspB ofBorrelia burgdorferi. Infect. Immun. 57 (1989) 2733–2741.
Postic, D., Edlinger, C., Richaud, C., Grimont, F., Dufresne, Y., Perolat, P., Baranton, G., Grimont, P. A. D. Two genomic species inBorrelia burgdorferi. Res. Microbiol. 141 (1990) 465–475.
Adam, T., Gassmann, G. S., Rasiah, C., Göbel, U. B. Phenotypic and genotypic analysis ofBorrelia burgdorferi isolates from various sources. Infect. Immun. 59 (1991) 2579–2585.
Baranton, G., Postic, D., Saint Girons, I., Boerlin, P., Piffaretti, J.-C., Assous, M., Grimont, P. A. D.: Delineation ofBorrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis. Intern. J. System Bacteriol. 42 (1992) in press.
Marconi, R. T., Lubke, L., Hauglum, W., Garon, C. F. Species-specific identification of and distinction betweenBorrelia burgdorferi genomic groups by using 16S rRNA-directed oligonucleotide probes. J. Clin. Microbiol. 30 (1992) 628–632.
Johnson, R. C., Kodner, C., Russel, M., Duray, P. Experimental infection of the hamster withB. burgdorferi. Ann. N. Y. Acad. Sci. 539 (1988) 258–263.
Barthold, S. W., Moody, K. D., Terwilliger, G. A., Duray, P. H., Jacoby, R. O., Steere, A. C. Experimental Lyme arthritis in rats infected withBorrelia burgdorferi. Infect. Dis. 157 (1988) 842–846.
Preac-Mursic, V., Patsouris, E., Wilske, B., Reinhardt, S., Groß, B., Mehraein, P. Persistence ofBorrelia burgdorferi and histopathological alterations in experimentally infected animals; comparison with histopathological findings in human Lyme disease. Infection 18 (1990) 332–341.
Schaible, U. E., Kramer, M. D., Museteanu, C., Zimmer, G., Mossmann, H., Simon, M. M. The severe combined immunodeficiency (scid) mouse. A laboratory model for the analysis of Lyme arthritis and carditis. J. Exp. Med. 170 (1989) 1427–1432.
Johnson, R. C., Kodner, C., Russell, M. Passive immunisation of hamsters against experimental infection with the Lyme disease spirochete. Infect. Immun. 53 (1986) 713–714.
Johnson, R. C., Kodner, C., Russel, M. Active immunization of hamsters against experimental infection withBorrelia burgdorferi. Infect. Immun. 54 (1986) 897–898.
Fikrig, E., Barthold, S. W., Kantor, F. S., Flavell, R. A. Protection of mice against the Lyme disease agent by immunizing with recombinant OspA. Science 250 (1990) 553–556.
Simon, M. M., Schaible, U. E., Kramer, M. D., Eckerskorn, C., Müller-Hermelink, H. K., Wallich, R. Recombinant outer surface protein A fromBorrelia burgdorferi induces antibodies protective against spirochetal infection in mice. J. Infect. Dis. 164 (1991) 123–132.
Schaible, U. E., Kramer, M. D., Eichmann, K., Modolell, M., Museteanu, C., Simon, M. M. Monoclonal antibodies specific for the outer surface protein (OspA) prevent Lyme borreliosis in severe combined immunodeficiency (scid) mice. Proc. Natl. Acad. Sci. USA 87 (1990) 3768–3772.
Zumstein, G., Fuchs, R., Hofmann, A., Preac-Mursic, V., Soutschek, E., Wilske, B. Genetic polymorphism of the gene encoding the outer surface protein A (OspA) ofBorrelia burgdorferi. Med. Microbiol. Immunol. 181 (1992) 57–70.
Barbour, A. G., Burgdorfer, W., Grunwald, E., Steere, A. C. Antibodies of patients with Lyme disease to components of theIxodes dammini spirochete. J. Clin. Invest. 72 (1983) 504–515.
Wilske, B., Preac-Mursic, V., Fuchs, R., Bruckbauer, H., Hofmann, A., Zumstein, G., Jauris, S., Soutschek, E., Motz, M. Immunodominant proteins ofBorrelia burgdorferi; implications for improving serodiagnosis of Lyme borreliosis. In:Neu, H. C. (ed.): New antibacterial strategies. Churchill Livingstone, London 1990, pp. 47–63.
Wilske, B., Preac-Mursic, V., Schierz, G., Liegl, G., Gueye, W. Detection of IgM- and IgG antibodies toBorrelia burgdorferi using different strains as antigen. Proceedings of the Lyme borreliosis update Europe. Baden 2.–4. Juni 1987. Zbl. Bakt. Suppl. 18 (1989) 299–309.
Bissett, M. L., Hill, W. Characterization ofBorrelia burgdorferi strains isolated fromIxodes pacificus ticks in California. J. Clin. Microbiol. 25 (1987) 2296–2301.
Fuchs, R., Jauris, S., Lottspeich, F., Preac-Mursic, V., Wilske, B., Soutschek, E. Molecular analysis and expression of aBorrelia burgdorferi gene encoding a 22 kDa protein (pC) inEscherichia coli. Mol. Microbiol. 6 (1992) 503–509.
Preac-Mursic, V., Wilske, B., Reinhardt, S. Culture ofBorrelia burgdorferi on six solid media. Eur. J. Microbiol. Infect. Dis. 10 (1991) 1076–1079.
Preac-Mursic, V., Wilske, B., Schierz, G. EuropeanBorrelia burgdorferi isolated from humans and ticks: culture conditions and antibiotic susceptibility. Zbl. Bakt. Hyg. A 263 (1986) 112–118.
Preac-Mursic, V., Wilske, B., Schierz, G., Holnburger, M., Süß, E. In vitro andin vivo susceptibility ofBorrelia burgdorferi. Eur. J. Clin. Microbiol. 6 (1987) 424–426.
Wilske, B., Fuchs, R., Jauris, S., Preac-Mursic, V., Soutschek, E., Zumstein, G.: Recombinant antigens for antibody detection in Lyme borreliosis. In 5 ECCMID Oslo (1991).
Preac-Mursic, V., Wilske, B., Schierz, G., Süß, E., Gross, B. Comparative antimicrobial activity of the new macrolides againstBorrelia burgdorferi. Eur. J. Clin. Microbiol. Infect. Dis. 8 (1989) 651–653.
Fikrig, E., Barthold, S. W., Persing, D. H., Sun, X., Kantor, F. S., Flavell, R. A. Borrelia burgdorferi strain 25015: characterization of outer surface protein A and vaccination against infection. J. Immun. 148 (1992) 2256–2260.
Duray, P. H., Steere, A. C. The spectrum of organ and systems pathology in human Lyme disease. Zbl. Bakt. Hyg. A 263 (1986) 169–178.
Mac Donald, A. Lyme disease: a neuro-ophtalmologic view. J. Clin. Neuro. Ophtalmol. 7 (1987) 185–190.
Lampert, F. Infantile multisystem inflammatory disease. Another case of a new syndrome. Eur. J. Pediatr. 444 (1984) 593–596.
Steere, A. C., Duray, P. H., Kaufman, G., Wormser, P. Unilateral blindness caused by infection with the Lyme disease spirochete,Borrelia burgdorferi. Ann. Intern. Med. 103 (1985) 382–384.
Camponovo, F., Meier, C. Neuropathy of vasculitis origin in a case of Garin-Bujadoux-Bannwarth syndrome with positiveBorrelia antibody response. J. Neurol. 233 (1986) 69–72.
Vallat, J. M., Hugon, J., Lubeau, M., Leboutet, M. J., Dumas, M., Deproges-Gotteron, M. Tick-bite meningoradiculoneuritis: clinical, electrophysiologic and histologic findings in ten cases. Neurology 37 (1987) 749–753.
Rothemund, E., Patsouris, E., Feiden, W., Pfister, W., Mehraein, S. Polyneuropathy in Lyme borreliosis: histopathological findings in sural nerve. Biopsy and experimental data. Clin. Neuropathol. 8 (1989) 247.
Chavanet, P., Pillon, D., Lancon, J. P., Waldner-Combernoux, A., Maringe, E., Portier, H. Granulomatous hepatitis associated with Lyme disease. Lancet ii (1987) 523–524.
Reimers, C. D., Pongratz, D. E., Neubert, U., Pilz, A., Hübner, G., Naegele, M., Wilske, B., Duray, P. H., de Koning, J. C. Myositis caused byB. burgdorferi: report of four cases. J. Neurol. Sci. 91 (1989) 215–226.
Abele, D. C., Anders, K. H., Chandler, F. W. Benign lymphocytic infiltration (Jessner-Kauot), another manifestation of borreliosis. J. Am. Acad. Dermatol. 21 (1989) 795–797.
Berger, B. W., Kaplan, M. H., Rothenberg, I. R., Barbour, A. G. Isolation and characterization of the Lyme disease spirochete from the skin of patients with erythema chronicum migrans. J. Am. Acad. Dermatol. 13 (1985) 444–449.
Duray, P. H. The surgical pathology of human Lyme disease: an enlarging picture. Am. J. Surg. Pathol. II (Suppl. 1) (1987) 47–60.
Pachner, A. R., Duray, P., Steere, A. C. Central nervous system manifestations of Lyme disease. Arch. Neurol. 46 (1989) 790–795.
Steere, A. C., Malawista, S. E., Hardin, J. A., Ruddy, S., Askenase, P. W., Andiman, W. A. Erythema chronicum migrans and Lyme arthritis: the enlarging clinical spectrum. Ann. Intern. Med. 86 (1977) 685–698.
Johnston, Y. E., Duray, P. H., Steere, A. C., Kashgarin, M., Buza, J., Malawista, S. E., Askenase, P. W. Lyme arthritis spirochetes found in synovial microangiopathic lesions. A. J. P. 118 (1985) 26–34.
Duray, P. H., Johnson, R. C. The histopathology of experimentally infected hamsters with the Lyme disease spirochete,Borrelia burgdorferi. (42251) Proc. Soc. Exp. Biol. Med. 181 (1986) 263–269.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Preac-Mursic, V., Wilske, B., Jauris, S. et al. Active immunization with pC protein ofBorrelia burgdorferi protects gerbils againstB. burgdorferi infection. Infection 20, 342–349 (1992). https://doi.org/10.1007/BF01710681
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01710681